Compared to PSA screening in prostate cancer, the urinary MALAT1 level is a more accurate diagnostic marker and helps to prevent 30.2–46.5% of unnecessary biopsies without missing any high-grade cancer in populations with PSA 4–10 ng/mL [18]. This evidence concerns the gene KLK3 and Familial prostate cancer.